The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
VEGF-A splicing: the key to anti-angiogenic therapeutics?
Open accessAbstract
The physiology of microvessels limits the growth and development of tumours. Tumours gain nutrients and excrete waste through growth-associated microvessels. New anticancer therapies target this microvasculature by inhibiting vascular endothelial growth factor A (VEGF-A) splice isoforms that promote microvessel growth. However, certain VEGF-A splice isoforms in normal tissues inhibit growth of microvessels. Thus, it is the VEGF-A isoform balance, which is controlled by mRNA splicing, that orchestrates angiogenesis. Here, we highlight the functional differences between the pro-angiogenic and the anti-angiogenic VEGF-A isoform families and the potential to harness the synthetic capacity of cancer cells to produce factors that inhibit, rather than aid, cancer growth.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer
Hurwitz, H., Fehrenbacher, L., Novotny, W., Cartwright, T., Hainsworth, J., Heim, W., Berlin, J., Baron, A., Griffing, S., Holmgren, E., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032691 · Cited by 10,968
Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma
Motzer, R. J., Hutson, T. E., Tomczak, P., Michaelson, M. D., Bukowski, R. M., Rixe, O., Oudard, S., Negrier, S., Szczylik, C., Kim, S. T., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065044 · Cited by 5,775
Mechanisms of angiogenesis and arteriogenesis
Carmeliet, P. (2000) · Nature Medicine · doi:10.1038/74651 · Cited by 4,162
Tumor Cells Secrete a Vascular Permeability Factor That Promotes Accumulation of Ascites Fluid
Senger, D. R., Galli, S. J., Dvorak, A. M., Perruzzi, C. A., Harvey, V. S., & Dvorak, H. F. (1983) · Science · doi:10.1126/science.6823562 · Cited by 3,972
Vascular Endothelial Growth Factor: Basic Science and Clinical Progress
Ferrara, N. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0027 · Cited by 3,687
Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., O'Shea, K. S., Powell-Braxton, L., Hillan, K. J., & Moore, M. W. (1996) · Nature · doi:10.1038/380439a0 · Cited by 3,628
VEGF receptor signalling ? in control of vascular function
Olsson, A.-K., Dimberg, A., Kreuger, J., & Claesson-Welsh, L. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1911 · Cited by 3,122
Regulation of angiogenesis by hypoxia: role of the HIF system
Pugh, C. W., & Ratcliffe, P. J. (2003) · Nature Medicine · doi:10.1038/nm0603-677 · Cited by 2,520
Ferrara, N., & Henzel, W. J. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92678-8 · Cited by 2,268
Vascular Permeability Factor, an Endothelial Cell Mitogen Related to PDGF
Keck, P. J., Hauser, S. D., Krivi, G., Sanzo, K., Warren, T., Feder, J., & Connolly, D. T. (1989) · Science · doi:10.1126/science.2479987 · Cited by 2,061
Mendel, D. B., Laird, A., Xin, X., Louie, S. G., Christensen, J. G., Li, G., Schreck, R., Abrams, T. J., Ngai, T. J., Lee, L. B., et al. (2003) · PubMed · Cited by 1,961
Kerbel, R. S. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0706596 · Cited by 1,948
VEGF Inhibition and Renal Thrombotic Microangiopathy
Eremina, V., Jefferson, J. A., Kowalewska, J., Hochster, H., Haas, M., Weisstuch, J., Richardson, C., Kopp, J. B., Kabir, M. G., Backx, P. H., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707330 · Cited by 1,504
Kendall, R. L., & Thomas, K. A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.22.10705 · Cited by 1,394
Anti-Angiogenesis: New Concept for Therapy of Solid Tumors
Folkman, J. (1972) · Annals of Surgery · doi:10.1097/00000658-197203000-00014 · Cited by 1,171
Autocrine VEGF Signaling Is Required for Vascular Homeostasis
Lee, S., Chen, T. T., Barber, C. L., Jordan, M. C., Murdock, J., Desai, S., Ferrara, N., Nagy, A., Roos, K. P., & Iruela-Arispe, M. L. (2007) · Cell · doi:10.1016/j.cell.2007.06.054 · Cited by 1,046
An Open-and-Shut Case? Recent Insights into the Activation of EGF/ErbB Receptors
Burgess, A. W., Cho, H.-S., Eigenbrot, C., Ferguson, K. M., Garrett, T. P. J., Leahy, D. J., Lemmon, M. A., Sliwkowski, M. X., Ward, C. W., & Yokoyama, S. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00350-2 · Cited by 909
Lambrechts, D., Storkebaum, E., Morimoto, M., Del-Favero, J., Desmet, F., Marklund, S. L., Wyns, S., Thijs, V., Andersson, J., van Marion, I., et al. (2003) · Nature Genetics · doi:10.1038/ng1211 · Cited by 860
Nishijima, K., Ng, Y.-S., Zhong, L., Bradley, J., Schubert, W., Jo, N., Akita, J., Samuelsson, S. J., Robinson, G. S., Adamis, A. P., et al. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.061237 · Cited by 707
Alternative splicing: multiple control mechanisms and involvement in human disease
Cáceres, J. F., & Kornblihtt, A. R. (2002) · Trends in Genetics · doi:10.1016/s0168-9525(01)02626-9 · Cited by 652
The vascular endothelial growth factor family of polypeptides
Ferrara, N., Houck, K. A., Jakeman, L. B., Winer, J., & Leung, D. W. (1991) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240470305 · Cited by 641
Aberrant and Alternative Splicing in Cancer
Venables, J. P. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1910 · Cited by 634
FERRARA, N. (2002) · Seminars in Oncology · doi:10.1016/s0093-7754(02)70064-x · Cited by 623
Takahashi, T., Ueno, H., & Shibuya, M. (1999) · Oncogene · doi:10.1038/sj.onc.1202527 · Cited by 571
Xia, P., Aiello, L. P., Ishii, H., Jiang, Z. Y., Park, D. J., Robinson, G. S., Takagi, H., Newsome, W. P., Jirousek, M. R., & King, G. L. (1996) · Journal of Clinical Investigation · doi:10.1172/jci119006 · Cited by 566
(2002) · PubMed · Cited by 550
Ferrara, N. (2002) · Seminars in Oncology · doi:10.1053/sonc.2002.37264 · Cited by 546
Sugimoto, H., Hamano, Y., Charytan, D., Cosgrove, D., Kieran, M., Sudhakar, A., & Kalluri, R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c300012200 · Cited by 538
VEGF165b, an Inhibitory Vascular Endothelial Growth Factor Splice Variant
Woolard, J., Wang, W.-Y., Bevan, H. S., Qiu, Y., Morbidelli, L., Pritchard-Jones, R. O., Cui, T.-G., Sugiono, M., Waine, E., Perrin, R., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0934 · Cited by 451
Self-citationVascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries
Ku, D. D., Zaleski, J. K., Liu, S., & Brock, T. A. (1993) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1993.265.2.h586 · Cited by 445
Baffert, F., Le, T., Sennino, B., Thurston, G., Kuo, C. J., Hu-Lowe, D., & McDonald, D. M. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00616.2005 · Cited by 374
Nowak, D. G., Woolard, J., Amin, E. M., Konopatskaya, O., Saleem, M. A., Churchill, A. J., Ladomery, M. R., Harper, S. J., & Bates, D. O. (2008) · Journal of Cell Science · doi:10.1242/jcs.016410 · Cited by 339
Self-citationGagnon, M. L., Bielenberg, D. R., Gechtman, Z., Miao, H.-Q., Takashima, S., Soker, S., & Klagsbrun, M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.040337597 · Cited by 313
Lamoreaux, W. J., Fitzgerald, M. E. C., Reiner, A., Hasty, K. A., & Charles, S. T. (1998) · Microvascular Research · doi:10.1006/mvre.1997.2056 · Cited by 278
Phosphorylated RNA polymerase II stimulates pre-mRNA splicing
Hirose, Y., Tacke, R., & Manley, J. L. (1999) · Genes & Development · doi:10.1101/gad.13.10.1234 · Cited by 240
Muller, Y. A., Christinger, H. W., Keyt, B. A., & de Vos, A. M. (1997) · Structure · doi:10.1016/s0969-2126(97)00284-0 · Cited by 237
Varey, A. H. R., Rennel, E. S., Qiu, Y., Bevan, H. S., Perrin, R. M., Raffy, S., Dixon, A. R., Paraskeva, C., Zaccheo, O., Hassan, A. B., et al. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604308 · Cited by 226
Self-citationPerrin, R. M., Konopatskaya, O., Qiu, Y., Harper, S., Bates, D. O., & Churchill, A. J. (2005) · Diabetologia · doi:10.1007/s00125-005-1951-8 · Cited by 217
Self-citationCébe Suarez, S., Pieren, M., Cariolato, L., Arn, S., Hoffmann, U., Bogucki, A., Manlius, C., Wood, J., & Ballmer-Hofer, K. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-006-6254-9 · Cited by 198
Solution structure of the heparin-binding domain of vascular endothelial growth factor
Fairbrother, W. J., Champe, M. A., Christinger, H. W., Keyt, B. A., & Starovasnik, M. A. (1998) · Structure · doi:10.1016/s0969-2126(98)00065-3 · Cited by 197
Schaal, T. D., & Maniatis, T. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.1.261 · Cited by 196
Type IV collagen-derived angiogenesis inhibitors
Mundel, T. M., & Kalluri, R. (2007) · Microvascular Research · doi:10.1016/j.mvr.2007.05.005 · Cited by 194
Foster, R. R., Hole, R., Anderson, K., Satchell, S. C., Coward, R. J., Mathieson, P. W., Gillatt, D. A., Saleem, M. A., Bates, D. O., & Harper, S. J. (2003) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00276.2002 · Cited by 177
Self-citationSimilarities and differences between the vascular endothelial growth factor (VEGF) splice variants
Neufeld, G., Cohen, T., Gitay-Goren, H., Poltorak, Z., Tessler, S., Sharon, R., Gengrinovitch, S., & Levi, B.-Z. (1996) · Cancer and Metastasis Reviews · doi:10.1007/bf00437467 · Cited by 165
Bates, D. O., & Curry, F. E. (1996) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1996.271.6.h2520 · Cited by 161
Self-citationKawamura, H., Li, X., Harper, S. J., Bates, D. O., & Claesson-Welsh, L. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6577 · Cited by 156
Self-citationStructure of a VEGF–VEGF receptor complex determined by electron microscopy
Ruch, C., Skiniotis, G., Steinmetz, M. O., Walz, T., & Ballmer‐Hofer, K. (2007) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1202 · Cited by 155
Expression of VEGFxxxb, the inhibitory isoforms of VEGF, in malignant melanoma
Pritchard‐Jones, R., Dunn, D., Qiu, Y., Varey, A. H. R., Orlando, A., Rigby, H., Harper, S. J., & Bates, D. O. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603839 · Cited by 133
Self-citationVascular endothelial growth factor and nephrin interact and reduce apoptosis in human podocytes
Foster, R. R., Saleem, M. A., Mathieson, P. W., Bates, D. O., & Harper, S. J. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00146.2004 · Cited by 132
Self-citationThe endogenous anti-angiogenic VEGF isoform, VEGF165b inhibits human tumour growth in mice
Rennel, E. S., Waine, E., Guan, H., Schüler, Y., Leenders, W. P. J., Woolard, J., Sugiono, M., Gillatt, D. A., Kleinerman, E. S., Bates, D. O., et al. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604309 · Cited by 131
Self-citationSaarela, J., Ylikärppä, R., Rehn, M., Purmonen, S., & Pihlajaniemi, T. A. (1998) · Matrix Biology · doi:10.1016/s0945-053x(98)90003-8 · Cited by 124
Exon repression by polypyrimidine tract binding protein
Amir-Ahmady, B., Boutz, P. L., Markovtsov, V. V., Phillips, M. L., & Black, D. L. (2005) · RNA · doi:10.1261/rna.2250405 · Cited by 118
Bakkour, N., Lin, Y., Maire, S., Ayadi, L., Mahuteau‐Betzer, F., Nguyen, C. H., Mettling, C., Portalès, P., Grierson, D. S., Chabot, B., et al. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030159 · Cited by 97
Coles, L. S., Bartley, M. A., Bert, A. G., Hunter, J., Polyak, S. W., Diamond, P., Vadas, M. A., & Goodall, G. J. (2004) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.2003.03968.x · Cited by 95
Cui, T.-G., Foster, R. R., Saleem, M. A., Mathieson, P. W., Gillatt, D. A., Bates, D. O., & Harper, S. J. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00337.2003 · Cited by 91
Self-citationWhittle, C., Gillespie, K. M., Harrison, R., Mathieson, P. W., & Harper, S. J. (1999) · Clinical Science · doi:10.1042/cs0970303 · Cited by 88
Self-citationClaffey, K. P., Senger, D. R., & Spiegelman, B. M. (1995) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/0167-4838(94)00144-6 · Cited by 85
Recombinant human VEGF165b protein is an effective anti-cancer agent in mice
Rennel, E., Hamdollah‐Zadeh, M., Wheatley, E. R., Magnussen, A., Schüler, Y., Kelly, S., Finucane, C. M., Ellison, D. H., Suarez, S., Ballmer‐Hofer, K., et al. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.05.027 · Cited by 80
Self-citationBevan, H. S., van den Akker, N. M. S., Qiu, Y., Polman, J. A. E., Foster, R. R., Yem, J., Nishikawa, A., Satchell, S. C., Harper, S. J., Groot, A. C. G., et al. (2008) · Nephron Physiology · doi:10.1159/000177614 · Cited by 75
Self-citationKeck, R. G., Berleau, L. T., Harris, R. J., & Keyt, B. A. (1997) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1997.0145 · Cited by 68
Koenigsberger, C., Chicca, J. J., Amoureux, M., Edelman, G. M., & Jones, F. S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.050578797 · Cited by 67
Qiu, Y., Bevan, H. S., Weeraperuma, S., Wratting, D., Murphy, D., Neal, C. R., Bates, D. O., & Harper, S. J. (2007) · The FASEB Journal · doi:10.1096/fj.07-9718com · Cited by 59
Self-citationStarovasnik, M. A., Christinger, H. W., Wiesmann, C., Champe, M., de Vos, A. M., & Skelton, N. J. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.3134 · Cited by 56
Díaz, R., Peña, C., Silva, J., Lorenzo, Y., García‐Barberán, V., García, J. M., Sánchez, A., Lara, P. E., Yuste, R. S., Bonilla, F., et al. (2008) · International Journal of Cancer · doi:10.1002/ijc.23619 · Cited by 55
Orf virus VEGF‐E NZ2 promotes paracellular NRP‐1/VEGFR‐2 coreceptor assembly via the peptide RPPR
Suarez, S., Grünewald, F. S., Jaussi, R., Li, X., Claesson, L., Spillmann, D., Mercer, A. A., Prota, A. E., & Ballmer‐Hofer, K. (2008) · The FASEB Journal · doi:10.1096/fj.08-107219 · Cited by 53
Pei, J., Zhang, J., Sumariwalla, P. F., Ni, I., Jorgensen, B., Crawford, D., Phillips, S. L., Feldmann, M., Shepard, H. M., & Paleolog, E. M. (2008) · Arthritis Research & Therapy · doi:10.1186/ar2447 · Cited by 53
In vivo inhibition of tumor angiogenesis by a soluble VEGFR-2 fragment
Kou, B., Li, Y., Zhang, L., Zhu, G., Wang, X., Li, Y., Xia, J., & Shi, Y. (2004) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2003.10.010 · Cited by 49
Muro, A. F., Iaconcig, A., & Baralle, F. E. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01201-0 · Cited by 47
Glass, C. A., Harper, S. J., & Bates, D. O. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2005.103127 · Cited by 45
Self-citationMitchell, C. A., Rutland, C. S., Walker, M., Nasir, M., Foss, A. J. E., Stewart, C., Gerhardt, H., Konerding, M. A., Risau, W., & Drexler, H. C. A. (2006) · Angiogenesis · doi:10.1007/s10456-006-9056-7 · Cited by 33
Therapeutic Potential of Inhibitory VEGF Splice Variants
Bates, D. O., & Harper, S. J. (2005) · Future Oncology · doi:10.2217/14796694.1.4.467 · Cited by 25
Self-citation
Cited by
Signal transduction by vascular endothelial growth factor receptors
Koch, S., Tugues, S., Li, X., Gualandi, L., & Claesson-Welsh, L. (2011) · Biochemical Journal · doi:10.1042/bj20110301 · Cited by 1,635
Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhinged
David, C. J., & Manley, J. L. (2010) · Genes & Development · doi:10.1101/gad.1973010 · Cited by 814
The role of microenvironment in tumor angiogenesis
Jiang, X., Wang, J., Deng, X., Xiong, F., Zhang, S., Gong, Z., Li, X., Cao, K., Deng, H., He, Y., et al. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01709-5 · Cited by 761
RNA splicing factors as oncoproteins and tumour suppressors
Dvinge, H., Kim, E., Abdel-Wahab, O., & Bradley, R. K. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.51 · Cited by 687
RNA splicing dysregulation and the hallmarks of cancer
Bradley, R. K., & Anczuków, O. (2023) · Nature Reviews Cancer · doi:10.1038/s41568-022-00541-7 · Cited by 579
Metadata
- Authors
- Harper, S. J., & Bates, D. O.
- Venue
- Nature Reviews Cancer
- Published
- 2008-10-16
- Volume
- 8
- Issue
- 11
- Pages
- 880-887
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W1976221241
- Cited by
- 514
- References
- 71
- FWCI
- 1.74
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.